Quadrature Capital
HCAT icon

Quadrature Capital’s Health Catalyst HCAT Stock Holding History

Quadrature Capital’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
+72,493
New +$105K ﹤0.01% 1421
2026
Q1 		– Sell
-26,888
Closed -$64.3K – 1589
2025
Q4 		$64.3K Buy
+26,888
New +$73.5K ﹤0.01% 1150
2024
Q4 		– Sell
-10,292
Closed -$83.8K – 1194
2024
Q3 		$83.8K Buy
+10,292
New +$74.4K ﹤0.01% 877
2023
Q1 		– Sell
-105,206
Closed -$1.12M – 1031
2022
Q4 		$1.12M Sell
105,206
-64,112
-38% -$619K 0.03% 329
2022
Q3 		$1.64M Buy
169,318
+137,902
+439% +$1.83M 0.05% 288
2022
Q2 		$456K Buy
+31,416
New +$536K 0.02% 441
2021
Q4 		– Sell
-6,712
Closed -$336K – 798
2021
Q3 		$336K Sell
6,712
-18,901
-74% -$1.03M 0.01% 471
2021
Q2 		$1.42M Buy
25,613
+7,096
+38% +$378K 0.05% 244
2021
Q1 		$865K Sell
18,517
-10,084
-35% -$488K 0.04% 343
2020
Q4 		$1.25M Buy
28,601
+6,398
+29% +$236K 0.06% 261
2020
Q3 		$812K Buy
+22,203
New +$754K 0.05% 392

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quadrature Capital's HCAT Position: Q2 2026 in Review

Quadrature Capital opened a new position in Health Catalyst (HCAT) in Q2 2026: 72,493 shares worth $144K. The stake represents ﹤0.01% of the portfolio and ranks #1421 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in HCAT as recently as Q4 2025.

Quadrature Capital first reported a position in HCAT in Q3 2020 and has held it in 11 quarters since. The position peaked at $1.64M in Q3 2022. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Quadrature Capital held 72,493 shares of Health Catalyst worth $144K as of Q2 2026.
  • Health Catalyst was a new Quadrature Capital position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1421 holding.
  • Quadrature Capital first reported a position in Health Catalyst in Q3 2020 and has held it in 11 quarters since.
  • Quadrature Capital's Health Catalyst position peaked at $1.64M in Q3 2022.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.